Targeted therapy in Thailand typically costs from $7,000 / ฿238,000 to $13,000 / ฿442,000. The price can vary depending on the type of cancer, the specific medication (such as tyrosine kinase inhibitors or monoclonal antibodies), the number of treatment cycles, and the hospital’s reputation. In the United States, the average cost is $40,000 / ฿1,360,000 (per ASCO). This means targeted therapy in Thailand is about 75% less expensive than in the U.S.
Thai hospitals usually include the cost of the medication, doctor’s fees, nursing care, routine bloodwork, and follow-up visits in their packages. In the U.S., medication, infusion fees, lab tests, and follow-up appointments are often billed separately. Always confirm exactly what is included with your treatment plan at each clinic.